24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Stem Cell
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:03
Netanyahu’s Likud emerges as Israel’s largest party, but exit polls point to another political deadlock
21:08
Israel turnout surpasses entire 2022 election total with two hours left to vote
20:53
Percepto co-founders depart as Israeli drone company expands into physical AI
16:15
Israel grounds civilian drones controlled by fiber-optic cables and SIM cards
More stories
Buzz
Most popular
Daily
Weekly
1
Microsoft offers buyouts to 60,000 workers but says layoffs remain an option
2
Intel to acquire Israeli quantum startup Classiq for $2.3 billion
3
Intel’s $2.3 billion Classiq deal follows years of personal investment by Lip-Bu Tan
4
Palantir CEO says Israel is the "minor exception" in AI race dominated by U.S. and China
5
Classiq founders set to pocket up to $100 million each in Intel’s $2.3 billion deal
More news
Stem Cell
3 stories about Stem Cell
Once worth NIS 1 billion, Pluri is now racing to avoid Nasdaq delisting
16.07.26
|
Almog Azar
After years of missed commercial breakthroughs, the stem-cell developer is betting its future on a new strategy and the longevity boom.
Somite raises $5.3 million to incorporate AI in stem cell therapy
16.04.24
|
James Spiro
The team of five scientists includes Micha Breakstone, an Israeli AI entrepreneur who sold Chorus.ai for $575 million
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes